{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T08:54:13Z","timestamp":1770972853974,"version":"3.50.1"},"reference-count":10,"publisher":"Codon Publications","issue":"3","license":[{"start":{"date-parts":[[2013,5,1]],"date-time":"2013-05-01T00:00:00Z","timestamp":1367366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1016\/j.aller.2012.04.006","type":"journal-article","created":{"date-parts":[[2012,10,10]],"date-time":"2012-10-10T16:01:25Z","timestamp":1349884885000},"page":"204-206","source":"Crossref","is-referenced-by-count":20,"title":["Injection site reaction to adalimumab: Positive skin test and successful rapid desensitisation"],"prefix":"10.15586","volume":"41","author":[{"given":"S.","family":"Bavbek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015e.","family":"Ataman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Bankova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Castells","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2012.04.006_bib0005","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1056\/NEJM200011303432202","article-title":"Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group","volume":"343","author":"Lipsky","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aller.2012.04.006_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta10420","article-title":"A systematic review of the effectiveness of adalimumab, etanercept and infliximab for the treatment of rheumatoid arthritis in adults and an economic evaluation of their cost-effectiveness","volume":"10","author":"Chen","year":"2006","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.aller.2012.04.006_bib0015","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1398-9995.2007.01536.x","article-title":"Injection site reactions to TNF-\u03b1 blocking agents with positive skin tests","volume":"63","author":"Benucci","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2012.04.006_bib0020","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jaci.2009.09.009","article-title":"Hypersensitivity reactions to mAbs: 105 desensitizations in 23 patients, from evaluation to treatment","volume":"124","author":"Brennan","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2012.04.006_bib0025","first-page":"246","article-title":"Successful adalimumab desensitization after generalized urticaria and rhinitis","volume":"19","author":"Rodriguez Jimenez","year":"2009","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.aller.2012.04.006_bib0030","first-page":"893","article-title":"Clinical, histological, and immunophenotypic characteristics of injection site reactions associated with etanercept: a recombinant tumor necrosis factor alpha-receptor: Fc fusion protein","volume":"137","author":"Zeltser","year":"2001","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2012.04.006_bib0035","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1001\/archderm.142.2.218","article-title":"Eosinophilic cellulites like reaction to subcutaneous etanercept injection","volume":"142","author":"Winfield","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2012.04.006_bib0040","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1001\/archderm.144.9.1190","article-title":"Immediate type I hypersensitivity response implicated in worsening injection site reactions to adalimumab","volume":"144","author":"Paltiel","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.aller.2012.04.006_bib0045","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/j.1398-9995.2011.02601.x","article-title":"Injection-site reaction to etanercept: role of skin test in the diagnosis of such reaction and successful desensitization","volume":"66","author":"Bavbek","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.aller.2012.04.006_bib0050","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.anai.2011.03.014","article-title":"Adalimumab desensitization after anaphylactic reaction","volume":"106","author":"Quercia","year":"2011","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030105461200170X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030105461200170X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:48:45Z","timestamp":1609454925000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030105461200170X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["S030105461200170X"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2012.04.006","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}